OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients

2 September 2024 (11:00 - 11:50)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Yuling Yu

Leuven (Belgium)

6 More presentations in this session

Presentation thumbnail

Expression of myostatin and folistatin as a response to high-load strength training to counteract the loss of muscle mass in heart failure with preserved ejection fraction

Doctor J. Lara Vargas (Ciudad de Mexico, MX)

Abstract Slides Video

Presentation thumbnail

Assessment of experimental circulating biomarkers in volume and pressure overload: insights from a cohort study

Mrs D. Csengeri (Hamburg, DE) Professor R. Schnabel (Hamburg, DE)

Abstract Slides Video

Presentation thumbnail

GJA4 gene inhibition may represent a potential target for novel antithrombotic therapies

Doctor D. Sa (Funchal, PT)

Abstract Slides Video

Presentation thumbnail

Circulating metabolites associate with the QT interval in individuals without prevalent cardiovascular disease.

Doctor W. Young (London, GB)

Abstract Slides Video

Presentation thumbnail

AI-CAC significantly improves on Coronary Artery Calcium (CAC) score for predicting all cardiovascular events: the Multi-Ethnic Study of Atherosclerosis

Access the full session

Session thumbnail

Biomarkers to assess cardiovascular risk

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET

You may be interested in

Congress Presentation

Markers of osteosarcopenia predicting outcomes in chronic heart failure: a prospective cohort study

Congress Presentation

Urinary proteomics signature of malignancy post heart transplantation is associated with mortality risk

Congress Session

Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources